MVS client unites forces to fight malariaMay 28, 2003

A recent article appearing in the Wall Street Journal highlighted the progressive, life-saving attempts being put forth by Medicines for Malaria Venture, a patent client with McKee, Voorhees, & Sease, PLC. MVS has assisted MMV in patenting ‘SPIRO and DISPIRO 1,2,4-Trioxolane Antimalarials’ U.S. Patent No. 6,486,199.MMV is a Geneva, Switzerland-based research group trying to pick up the pieces from past failed attempts to bring a better drug to fight malaria to the market in a timely fashion. To read more, log on to www.wsj.com and in the search field, type